Leaflet: information for the user
Distraneurine 192mg soft capsules
Clometiazol
Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the leaflet
5 Storage of Distraneurine
Distraneurine contains the active substance clometiazol, which belongs to the group of hypnotics and sedatives. Distraneurine is used for the treatment of:
Do not take Distraneurine:
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Distraneurine, especially if:
Risk of psychological and/or physical dependence: this may occur after prolonged administration of high doses. Abrupt discontinuation of treatment may cause withdrawal symptoms such as convulsions, tremors, and organic psychosis. To avoid the onset of withdrawal syndrome, it is recommended to gradually reduce the dose, according to your doctor's instructions.
If you are not sure if the above applies to you, consult your doctor or pharmacist.
Children and adolescents
Distraneurine is not recommended for children and adolescents under 18 years of age, as there is not enough information about its use in this age group.
Elderly patients
Caution is recommended, as in elderly patients, there may be a delay in the elimination of the active substance of Distraneurine, resulting in higher levels of clometiazol in the blood.
Other medicines and Distraneurine
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medicine. This is because Distraneurine may affect how some medicines work, and some medicines may have an effect on Distraneurine.
Tell your doctor or pharmacist if you are taking any of the following medicines:
Use of Distraneurine with alcohol
Do not drink alcohol while taking Distraneurine, as it may cause difficulty breathing that can be severe. This can have fatal consequences.
If you are taking Distraneurine, tell your doctor if you have recently consumed any alcoholic beverages.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Distraneurine should not be taken during pregnancy, unless, in your doctor's judgment, the expected benefit of treatment outweighs the potential risk.
Breastfeeding
This medicine should not be used during breastfeeding, as it passes into breast milk and the effects on infants are unknown. If treatment with this medicine is necessary, breastfeeding should be discontinued.
Driving and using machines
Distraneurine is a medicine that causes sleepiness. Do not drive or use machines if you feel drowsy or if you notice that your attention and reaction are reduced. Pay special attention when starting treatment or if the dose is increased.
Distraneurine contains sorbitol
This medicine contains 7 mg of sorbitol (E420) per capsule.
Follow the instructions for administration of this medicine exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again. Your doctor will prescribe the minimum number of doses necessary, review the treatment periodically, and discontinue it gradually as soon as possible. The maximum recommended treatment duration is 10 consecutive days.
The soft capsules should be swallowed whole with a sufficient amount of water and should not be chewed or crushed.
The recommended dose is:
Treatment of restlessness, agitation, and organic confusion in elderly patients
One capsule three times a day.
Treatment of severe insomnia in elderly patients
Two capsules before bedtime. Your doctor may reduce the dose if you experience morning drowsiness.
Treatment of symptoms of alcohol withdrawal and delirium tremens
The dose will be adjusted individually. Your doctor will initially prescribe a high dose to reduce it gradually afterwards.
Your doctor may also reduce your dose if you are of Japanese origin or have liver problems.
If you take more Distraneurine than you should
If you take more Distraneurine than prescribed by your doctor, you may experience the following effects: drowsiness, confusion, unconsciousness, increased mucous formation in the upper respiratory tract, low blood pressure, low body temperature, and even cardiopulmonary depression (slowing of breathing and heart pumping) and deep coma, in some cases with a fatal outcome. The risk increases if the overdose of clometiazol is accompanied by substances that decrease the function of the central nervous system (including alcohol), especially in patients with liver problems.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Distraneurine
Do not take a double dose to make up for forgotten doses.
If you stop taking Distraneurine
Talk to your doctor if you want to stop taking Distraneurine. You may experience withdrawal symptoms, such as convulsions, tremors, or organic psychosis, after abrupt cessation, especially after taking high doses. The dose of Distraneurine should be gradually reduced over several days, according to your doctor's instructions.
If you have any other doubts about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In rare cases, serious allergic reactions have been reported. If you have a serious allergic reaction, stop taking Distraneurine and seek medical attention immediately. You may need urgent medical treatment. The signs can include:
Other possible side effects are:
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: frequency cannot be estimated from the available data
Reporting of side effects
If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Monitoring System: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store below 30 °C.
Do not use this medicine after the expiry date stated on the bottle after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Distraneurine
Appearance of the product and pack contents
Distraneurine capsules are soft capsules of a grayish-brown color. They are available in amber glass bottles with 30 capsules, closed with a white screw cap.
Marketing authorization holder
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24, 17489 Greifswald, Germany
Manufacturer
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 23-24, 17489 Greifswald, Germany
Local representative
Laboratorios Rubió, S.A.
Industria, 29 - Pol. Ind. Comte de Sert
08755 Castellbisbal (Barcelona)
Spain
Date of the last revision of this leaflet:April 2020
The average price of DISTRANEURINE 192 mg SOFT GEL CAPSULES in October, 2025 is around 8.27 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.